Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/146526
| Title: | Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC. | Authors: | Rudin, Charles M. Kim, Hye Ryun Navarro, Alejandro Gottfried, Maya Peters, Solange Csoszi, Tibor Cheema, Parneet Kaur Rodríguez Abreu, Delvys Wollner, Mira Yang, James Chih-Hsin Mazieres, Julien Kato, Terufumi Kalemkerian, Gregory Peter Dettman, Elisha Edmondson, Mackenzie Vajdi, Amir Loboda, Andrey El-Osta, Hazem Edmond Zhao, Bin Awad, Mark M. |
UNESCO Clasification: | 32 Ciencias médicas 320101 Oncología 320508 Enfermedades pulmonares |
Issue Date: | 2023 | Journal: | Journal of Clinical Oncology | URI: | https://accedacris.ulpgc.es/handle/10553/146526 | ISSN: | 0732-183X | DOI: | 10.1200/JCO.2023.41.16_suppl.8503 | Source: | Journal Of Clinical Oncology [ISSN 0732-183X], v. 41 (16_SUPPL) sup. 16_SUPPL, p. 8503, (Junio 2023) |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.